Atlas Trials

Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

Clinical trial NCT07630103 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07630103
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Breast Cancer
Start date
2026-06-01
Primary completion
2031-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.